Robotic technology quantifies novel perceptual-motor impairments in patients with chronic kidney disease.
Jessica Anne VanderlindenRachel Mary HoldenStephen Harold ScottJohn Gordon BoydPublished in: Journal of nephrology (2021)
It is feasible to quantify neurocognitive impairments in patients with CKD using robotic technology. Kinarm characterized more patients with CKD as impaired, and importantly identified novel perceptual-motor impairments in these patients, when compared to traditional assessments.